Phosphodiesterase 5: A Novel Therapeutic Target in Long QT Syndrome

Circ Res. 2021 Sep 3;129(6):666-668. doi: 10.1161/CIRCRESAHA.121.319851. Epub 2021 Sep 2.
No abstract available

Keywords: Editorials; arrhythmia; long QT syndrome; phosphodiesterase inhibitors; sarcoplasmic reticulum.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Humans
  • Long QT Syndrome* / drug therapy
  • Long QT Syndrome* / genetics

Substances

  • Cyclic Nucleotide Phosphodiesterases, Type 5